Patient-derived glioblastoma stem cells respond differentially to targeted therapies

The dismal prognosis of glioblastoma is, at least in part, attributable to the difficulty in eradicating glioblastoma stem cells (GSCs). However, whether this difficulty is caused by the differential responses of GSCs to drugs remains to be determined. To address this, we isolated and characterized...

Descripción completa

Detalles Bibliográficos
Autores principales: Kanabur, Pratik, Guo, Sujuan, Rodgers, Cara M., Simonds, Gary R., Kelly, Deborah F., Gourdie, Robert G., Verbridge, Scott S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5349922/
https://www.ncbi.nlm.nih.gov/pubmed/27863440
http://dx.doi.org/10.18632/oncotarget.13415

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5349922/
https://www.ncbi.nlm.nih.gov/pubmed/27863440
http://dx.doi.org/10.18632/oncotarget.13415

Ejemplares similares